• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Disc Medicine Presents DISC-0974 Data In Myelofibrosis At ASCO

    FIRSTWORD PHARMA

    Disc Completes Enrollment in APOLLO Trial for EPP Protoporphyria

    GLOBENEWSWIRE

    Disc Lays Off 20% Of Workforce In Wake Of FDA Rejection

    FIERCE PHARMA

    Disc Medicine To Participate In Upcoming Investor Conferences

    GLOBENEWSWIRE

    Disc Medicine Showcases 2026 Achievements And Business Goals

    GLOBENEWSWIRE

    Disc Medicine Names Lisa Amaya Price, MBA, as Chief HR Officer

    GLOBENEWSWIRE

    Disc Medicine To Present At J.P. Morgan Healthcare Conference

    GLOBENEWSWIRE

    Disc Med Reveals Promising RALLY-MF Ph2 Results in Myelofibrosis

    GLOBENEWSWIRE

    Disc Medicine Reports Q3 2025 Financial Results & Business

    GLOBENEWSWIRE

    Disc Medicine Presents Initial Data From RALLY-MF Ph2 Trial

    GLOBENEWSWIRE

    Disc Medicine to Participate in Upcoming Investor Conferences

    GLOBENEWSWIRE

    Disc Medicine Prices $250M Upsized Public Offering

    GLOBENEWSWIRE

    Disc Medicine Updates Hematology Portfolio And Business Goals

    GLOBENEWSWIRE

    Disc Medicine Plans Public Offering Of Common Stock & Pre-Funded

    GLOBENEWSWIRE

    Disc Medicine To Present Phase 1B Trial Data Of DISC-0974 In CKD

    GLOBENEWSWIRE

    Disc Medicine Receives FDA Priority Voucher For Bitopertin

    GLOBENEWSWIRE

    Disc Medicine to Participate in Upcoming Investor Conferences

    GLOBENEWSWIRE

    Disc Medicine to Submit NDA for Bitopertin in EPP

    GLOBENEWSWIRE

    Disc Medicine Receives FDA Fast Track Designation for DISC-0974

    GLOBENEWSWIRE

    Disc Presents Initial Positive Data from Ongoing Phase 1b/2 Trial of DISC-0974

    GLOBENEWSWIRE

    Disc Medicine Initiates a Phase 1 Study of DISC-3405

    GLOBENEWSWIRE

    Disc Medicine Receives FDA Fast Track Designation for MWTX-003

    GLOBENEWSWIRE

    Disc Medicine Announces Collaboration with NIH for PII Study of Bitopertin

    GLOBENEWSWIRE

    Disc Medicine Initiates a Phase 1b/2 Study of DISC-0974 in Adults with NDD-CKD

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.